Form 4 for SER Serina Therapeutics, Inc.
Accepted 2026-05-22 16:59:44 ET · period of report 2026-05-19 · accession 0002016188-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-22 16:59 | 2026-05-19 | SER | Marshall Richard Peter | Dir | P - Purchase | $1.65 | +12.2K | 12.2K | New | +$20.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-19 | P | A | 12,183 | $1.65 | 12,183 | D | — | — | (F1) The price reflects the weighted average purchase price of multiple transactions ranging from a low purchase price of $1.59 per share to a high purchase price of $1.73 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each price. |